http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FI-54485-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-18
filingDate 1971-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1978-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_792d9d0876d171567987f43fb3606605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bcec163e4d94a909aa599a4e647a550
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a74aec48d8919d18da04cb5d711f9c73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cd75020cdfd0b564671aff27fcb22c8
publicationDate 1978-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FI-54485-B
titleOfInvention PROTECTION OF ANTIBACTERIAL ANTIBACTERIA 3-STATIONARY SUBSTITUTES OF 3-ACYLUREIDO- (THIENYL-CYCLOHEXENYL-PHENYL) METHYLPENICILLINER
abstract 1301962 Ureido penicillins BAYER AG 25 May 1971 [25 May 1970 1 Feb 1971 3 Feb 1971] 16881/71 Heading C2A The invention comprises penicillins of the general Formula (I) in which general formula A is a group having one of the general formulµ (2), (3) or (4) in which formulµ X is a hydrogen atom or an alkyl, alkenyl, cycloalkyl or cycloalkenyl group with up to ten carbon atoms, or a vinyl, arylvinyl, mono-, di- or tri-haloalkyl, alkyamino, dialkylamino, monoarylamino, arylalkylamino or aryloxy group or an alkoxy or aryloxy group, or an alkoxy or aryloxy group with up to 8 carbon atoms, or a cycloalkoxy group with up to 7 carbon atoms, or a group having one of the general formulµ (lower alkyl)-O-V-, (lower alkyl)-S-V-, N#C-V-,(lower alkyl)-O-CO-V- or in which formulµ V is a bivalent organic radical with 1 to 3 carbon atoms, lower alkyl groups have up to six carbon atoms; n is 0, 1 or 2 and R 1 , R 2 and R 3 may be the same or different and are each hydrogen, chlorine, bromine, iodine or fluorine, nitro, nitrile, di(lower alkyl)amino, di(lower alkyl)ammo-carbonyl, lower alkanoylamino, lower alkoxy carbonyl, lower alkanoyloxy, lower alkyl, lower alkoxy, sulphamyl or trifluoromethyl; Y is an alkyl, alkenyl, cycloalkyl or cycloalkenyl group with up to 10 carbon atoms, or a vinyl, propenyl, mono-, di- or tri-halo (lower alkyl) aryl or heterocyclic group, or an aralkyl group with up to 8-carbon atoms; #Z- is a divalent group having one of the formulµ in which formulµ n is 3, 4 or 5 and the arrow # means that the two free valencies of the group Z are not arbitrarily joined to the N and C atoms of the group (3) but are oriented as indicated by the arrow. Q is a divalent group, B is a group having one of the general formulµ in which formulµ R 4 , R 5 and R 6 may be the same or different and are each hydrogen, halogen, lower alkyl, lower alkoxy, lower alkylthio, lower alkylthionyl, lower alkylsulphonyl, nitro, di(lower alkyl) amino, lower alkanoylamino, hydroxy, or lower alkanoyloxy and in which the chirality centre C*can have either of the two possible R and S stereoisomeric configurations or can be a mixture of these two diastereosiomers. The invention also comprises salts of the above penicillins. A process for the production of penicillins of Formula (I) comprises reacting 6-amino-penicillanic acid or a compound of the general formula (46) or (47) in which R 7 , R 8 and R 9 are the same or different alkyl groups having up to 6 carbon atoms, at a temperature of -30‹ C. to +50‹ C. with a carboxylic acid of general formula If compounds of formula (46) or (47) are used, the reaction is carried out in an anhydrous solvent which is free of hydroxyl groups, with or without a base, and if 6-aminopenicillanic acid is used, the reaction is carried out in a solvent in the presence of a base. Various modifications of the process are described. Antibiotically active pharmaceutical compositions, which contain as active ingredient at least one penicillin of Formula (I) or a pharmaceutically acceptable salt thereof, have been prepared. Such compositions also contain a pharmaceutically acceptable carrier which may be solid or liquid. These compositions may be adapted for parenteral or oral administration and may be prepared in dosage unit form.
priorityDate 1970-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID807
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419515849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7057887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455784172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313

Total number of triples: 51.